Preprint: Please note that this article has not completed peer review.

Comparison of the effects of intravenous and inhalational anesthesia on postoperative pulmonary complications after oral and maxillofacial surgery with free flap reconstruction: a double-blind, randomized, controlled trial

Dan Zhou, Xi Zhu, Likuan Wang, Xudong Yang, Yun Liu, Xiang Zhang

Abstract

Background: The effects of intravenous and inhalation anesthesia on intraoperative and postoperative pulmonary inflammatory responses have been reported in many studies. However, the differences in clinical postoperative pulmonary complications (PPCs) have rarely been studied, except in cases of lung resection. The main goal of the current study was to assess the impact of sevoflurane and propofol on the incidence of PPCs in patients undergoing oral and maxillofacial surgery. Methods: In this double-blind, randomized, controlled trial, we randomly assigned 220 adults at intermediate-to-high risk of pulmonary complications after oral and maxillofacial surgery to either propofol or sevoflurane as a general anesthetic. The occurrence of pulmonary complications according to the Clavien-Dindo score was defined as the primary (within 7 days after surgery) outcome. Results: The two intervention groups had similar characteristics at baseline. The PPCs incidence during 7 days after surgery was 32.4% and 18.2% in the propofol and sevoflurane groups, respectively (adjusted relative risk, 0.44; 95% confidence interval [CI], 0.22 to 0.91; P = 0.027). The corresponding incidence of PPCs in patients who underwent tracheotomy after surgery was 44.8% and 24.5% (adjusted relative risk, 0.39; 95% CI, 0.17 to 0.91; P = 0.030). Intergroup difference in the time to occurrence of the first PPC after surgery was significant (P = 0.021). There was no difference in postoperative hospital stay between the two groups. Conclusions: Compared with intravenous anesthesia, the administration of sevoflurane reduces the frequency of PPCs in intermediate-risk and high-risk patients undergoing oral and maxillofacial surgery with microvascular reconstruction. Trial registration: Clinical Trail Registration: ChiCTR1800015347; Registered March 25, 2018.

Keywords
Intravenous anesthesia, Inhalational anesthesia, Postoperative pulmonary complications, Oral and maxillofacial surgery

Figures

Introduction

METHODS

Results

Discussion

Conclusion

Abbreviations

Declarations

References

Tables

STATUS: In Revision

Comments: 0
PDF Downloads: 0
HTML Views: 3

Integrity Check:

Peer Review Timeline

Version 1

Posted 08 Aug, 2019

  • No community comments so far
  • Review #5 received

    Received 20 Aug, 2019

  • Editorial decision: Major revision

    On 20 Aug, 2019

  • Review #4 received

    Received 18 Aug, 2019

  • Review #3 received

    Received 18 Aug, 2019

  • Reviewer #4 agreed

    On 12 Aug, 2019

  • Review #1 received

    Received 12 Aug, 2019

  • Reviewer #5 agreed

    On 12 Aug, 2019

  • Review #2 received

    Received 12 Aug, 2019

  • Reviewer #2 agreed

    On 08 Aug, 2019

  • Reviewer #3 agreed

    On 08 Aug, 2019

  • 6 reviewer(s) invited

    Invitations sent on 08 Aug, 2019

  • Reviewer #1 agreed

    On 08 Aug, 2019

  • Submission checks complete

    On 01 Aug, 2019

  • Editor assigned

    On 23 Jul, 2019

  • Editor invited

    On 22 Jul, 2019

  • First submitted

    On 21 Jul, 2019

More from BMC Anesthesiology

Comments (0)

Comments can take the form of short reviews, notes or questions to the author. Comments will be posted immediately, but removed and moderated if flagged.

Learn more about our company.

Preprint: Please note that this article has not completed peer review.

Comparison of the effects of intravenous and inhalational anesthesia on postoperative pulmonary complications after oral and maxillofacial surgery with free flap reconstruction: a double-blind, randomized, controlled trial

Dan Zhou, Xi Zhu, Likuan Wang, Xudong Yang, Yun Liu, Xiang Zhang

STATUS: In Revision

Comments: 0
PDF Downloads: 0
HTML Views: 3

Integrity Check:

  • Article

  • Peer Review Timeline

  • Related Articles

  • Comments

Abstract

Background: The effects of intravenous and inhalation anesthesia on intraoperative and postoperative pulmonary inflammatory responses have been reported in many studies. However, the differences in clinical postoperative pulmonary complications (PPCs) have rarely been studied, except in cases of lung resection. The main goal of the current study was to assess the impact of sevoflurane and propofol on the incidence of PPCs in patients undergoing oral and maxillofacial surgery. Methods: In this double-blind, randomized, controlled trial, we randomly assigned 220 adults at intermediate-to-high risk of pulmonary complications after oral and maxillofacial surgery to either propofol or sevoflurane as a general anesthetic. The occurrence of pulmonary complications according to the Clavien-Dindo score was defined as the primary (within 7 days after surgery) outcome. Results: The two intervention groups had similar characteristics at baseline. The PPCs incidence during 7 days after surgery was 32.4% and 18.2% in the propofol and sevoflurane groups, respectively (adjusted relative risk, 0.44; 95% confidence interval [CI], 0.22 to 0.91; P = 0.027). The corresponding incidence of PPCs in patients who underwent tracheotomy after surgery was 44.8% and 24.5% (adjusted relative risk, 0.39; 95% CI, 0.17 to 0.91; P = 0.030). Intergroup difference in the time to occurrence of the first PPC after surgery was significant (P = 0.021). There was no difference in postoperative hospital stay between the two groups. Conclusions: Compared with intravenous anesthesia, the administration of sevoflurane reduces the frequency of PPCs in intermediate-risk and high-risk patients undergoing oral and maxillofacial surgery with microvascular reconstruction. Trial registration: Clinical Trail Registration: ChiCTR1800015347; Registered March 25, 2018.

Figures

Introduction

METHODS

Results

Discussion

Conclusion

Abbreviations

Declarations

References

Tables